| Drug Name |
Triprolidine hydrochloride |
| Drug ID |
BADD_D02296 |
| Description |
First generation histamine H1 antagonist used in allergic rhinitis; asthma; and urticaria. It is a component of cough and cold medicines. It may cause drowsiness. |
| Indications and Usage |
For the symptomatic relief of seasonal or perennial allergic rhinitis or nonallergic rhinitis; allergic conjunctivitis; and mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Also used in combination with other agents for the symptomatic relief of symptoms associated with the common cold. |
| Marketing Status |
approved |
| ATC Code |
R06AX07 |
| DrugBank ID |
DB00427
|
| KEGG ID |
D01782
|
| MeSH ID |
D014311
|
| PubChem ID |
5702129
|
| TTD Drug ID |
D0E8CI
|
| NDC Product Code |
58809-651; 70868-730; 66651-906; 70154-204; 69367-253; 28595-808; 0536-1257; 62331-046; 28595-801; 28595-802; 57218-900; 71321-701 |
| UNII |
YAN7R5L890
|
| Synonyms |
Triprolidine | Triprolidine Hydrochloride | Hydrochloride, Triprolidine | Triprolidine Monohydrochloride | Triprolidine Monohydrochloride, Monohydrate | Pro Actidil | Triprolidine Hydrochloride Anhydrous | Anhydrous, Triprolidine Hydrochloride | Hydrochloride Anhydrous, Triprolidine | Triprolidine Oxalate | Triprolidine Oxalate, (trans)-Isomer | Triprolidine, (Z)-Isomer | Actidil | Triprolidine Monohydrochloride, (Z)-Isomer |
